Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
Marion V. Guérin(Inserm), Nadège Bercovici(Centre National de la Recherche Scientifique), Matthieu Bénard(Centre National de la Recherche Scientifique), Estelle Dransart(Centre National de la Recherche Scientifique), Fabienne Régnier(Délégation Paris 5), Lene Vimeux(Délégation Paris 5), Ludger Johannes(Centre National de la Recherche Scientifique), Maxime Thoreau(Délégation Paris 5), Alain Trautmann(Centre National de la Recherche Scientifique), Hweixian Leong Penny(Amgen (United States))
Cited by 2
Related Papers
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
|Proceedings of the National Academy of Sciences|2018|948
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
|Nature Cancer|2023|137
The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer
|Frontiers in Immunology|2019|129